Sutro Biopharma (STRO) EBITDA Margin Growth (1y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -957.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 8,807.00 |
| 10 | Sutro Biopharma | 242.87 Mn | 242.87 Mn | - | -13,584.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -13,584.00 |
| Sep 30, 2025 | 29,723.00 |
| Jun 30, 2025 | 26,826.00 |
| Mar 31, 2025 | -76,695.00 |
| Dec 31, 2024 | -47,861.00 |
| Sep 30, 2024 | -53,710.00 |
| Jun 30, 2024 | 17,001.00 |
| Mar 31, 2024 | -10,179.00 |
| Dec 31, 2023 | 60,817.00 |
| Sep 30, 2023 | -17,572.00 |
| Jun 30, 2023 | -37,454.00 |
| Mar 31, 2023 | 33,033.00 |
| Dec 31, 2022 | -24,137.00 |
| Sep 30, 2022 | 32,277.00 |
| Jun 30, 2022 | -3,402.00 |
| Mar 31, 2022 | -53,393.00 |
| Dec 31, 2021 | -2,874.00 |
| Sep 30, 2021 | -34,755.00 |
| Jun 30, 2021 | 13,842.00 |
| Mar 31, 2021 | 13,851.00 |
| Dec 31, 2020 | -16,935.00 |
| Sep 30, 2020 | 4,416.00 |
| Jun 30, 2020 | -4,335.00 |
| Mar 31, 2020 | -10,285.00 |
| Dec 31, 2019 | -11,360.00 |
| Sep 30, 2019 | 2,589.00 |
| Jun 30, 2019 | 8,190.00 |
| Mar 31, 2019 | 3,669.00 |
| Dec 31, 2018 | 35,829.00 |
| Sep 30, 2018 | -12,353.00 |